Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study

Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study

Background: No clear evidence supports the use of cefiderocol as first line treatment in A. baumannii infections. Methods: We conducted an observational retrospective/prospective multicenter study including all patients> 18 years with carbapenem-resistant A. baumannii (CRAB) infections treated wi...

Full description

Bibliographic Details
Main Authors: Federica Calò, Lorenzo Onorato, Ilaria De Luca, Margherita Macera, Caterina Monari, Emanuele Durante-Mangoni, Alessia Massa, Ivan Gentile, Giovanni Di Caprio, Pasquale Pagliano, Fabio Giuliano Numis, Pasquale Iuliano, Antonio Riccardo Buonomo, Sebastiano Leone, Paolo Maggi, Nicola Coppola
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Journal of Infection and Public Health
Subjects:
Cefiderocol
A. baumannii
Carbapenem-resistant
Mortality
Clinical failure
Microbiological failure
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034123002150

Internet

http://www.sciencedirect.com/science/article/pii/S1876034123002150

Similar Items